Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03806153
Other study ID # 2017/385/HP
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date March 1, 2026

Study information

Verified date January 2019
Source University Hospital, Rouen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In France, nearly 3% of children are conceived by the technique of Assisted Reproductive Medicine, of which nearly 70% by in vitro fertilization (IVF). The rates of clinical pregnancy by oocyte retrieval or embryo transfer have not changed much. The use of mono-embryo transfer reduces the risk of multiple pregnancies and associated obstetric complications. The choice of embryo to transfer or freeze is a key element in improving the chances of success of IVF. It is usually based on conventional morphological criteria (reference method) that are punctual, qualitative and subjective. However, embryo morphology at early stages has little predictive value for obtaining a late-stage embryo and its chances of implantation. The recent use of time-lapse technology during embryonic culture makes it possible to associate morphological criteria with continuous monitoring of the kinetics of embryonic development. The choice of the embryo to be transferred is then made according to morphokinetic criteria (conventional morphological criteria to which are added the data of the kinetics of embryonic development).

Two recent retrospective studies give contradictory results, the first shows higher birth rates in the group of embryos selected according to conventional morphological criteria, the second concludes that morphokinetic analysis is superior. Morphokinetic criteria would also be more objective and reproducible. However, the use of morphokinetic parameters remains controversial in the literature.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 520
Est. completion date March 1, 2026
Est. primary completion date March 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 59 Years
Eligibility Inclusion Criteria:

1. For the couple:

- Couple whose two members are 18 years old and over,

- Couple whose two members are affiliated to a social security scheme,

- Couple whose two members read and understood the newsletter and signed the consent form for their participation in this research.

2. For the conditions of realization of the ICSI attempt:

- Couple supported for a 1st or 2nd attempt at in vitro fertilization with sperm microinjection (ICSI) for male infertility,

- In vitro fertilization attempt performed with micro-injection of fresh ejaculated spermatozoa.

3. For the man:

- Couple whose man has an alteration of at least one of the sperm parameters according to the WHO (WHO, 2010) for the number, concentration, vitality, mobility or morphology according to the modified David classification (Auger and Eustache, 2000).

Exclusion Criteria:

1. For the couple:

- Couple whose wife is under 18 and over 42 and / or the male is under 18 and over 59

- Couple already included in the protocol "EMCIMO" for a previous attempt,

- Couple of which one or both members is deprived by an administrative or judicial decision or subject to a legal measure of protection of the majors (safeguard of justice or tutelage or curatorship),

- Couple where one or both members do not speak or understand French.

2. For the conditions of realization of the ICSI attempt:

- In vitro fertilization attempt with the micro-injection of testicular spermatozoa, epididymal, previously frozen or resulting from a retrograde ejaculation.

3. For the man:

- Severe oligozoospermia (<100,000 spermatozoa / ejaculate).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Morphokinetic
The embryos will be observed at a fixed time and according to morphological criteria (Alpha Specialist Group in Reproductive Medicine and ESHRE, 2011). and all the films obtained will be analyzed. Embryos will be classified according to morphokinetic criteria (Ciray et al., 2014).

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Rouen

Outcome

Type Measure Description Time frame Safety issue
Primary The primary endpoint of this study will be the live birth rate by fresh embryo transfer(s). 36 months
See also
  Status Clinical Trial Phase
Recruiting NCT05788822 - MVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive Technology N/A
Recruiting NCT05971849 - Dampening the Reproductive Axis With Continuous Kisspeptin Phase 1
Terminated NCT05901467 - Recall by Genotype: Neuropeptide Stimulation Phase 1
Completed NCT03922087 - No-worry Baby Project
Active, not recruiting NCT05866484 - Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)
Not yet recruiting NCT06357208 - IMPACT OF BREATH CONTROL AND RETENTION ON PATIENT STRESS. E.S IN MEDICALLY ASSISTED REPRODUCTION BREATH HOLD TO BREATH BETTER PROGRAM N/A
Recruiting NCT03317548 - A Comparison of Clinical Outcomes of Warmed Embryo Vitrified at 2PN Stage and Fresh Embryo Transfers N/A
Suspended NCT05506800 - Guangzhou Women's Health Cohort Study (GWHCS)
Completed NCT02341365 - Vitamin D Influence on Oocyte Donation N/A
Recruiting NCT05971836 - The Molecular Basis of Inherited Reproductive Disorders
Completed NCT04854707 - An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data
Completed NCT04361292 - Ejaculatory Abstinence in IUI Cycles N/A
Completed NCT03065114 - Retrospective Study on Clinical Results of Preimplantation Genetic Screening at Different Embryo Stage N/A